Liz Elmhirst
Corporate Officer/Principal chez Achilles Therapeutics UK Ltd.
Postes actifs de Liz Elmhirst
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Historique de carrière de Liz Elmhirst
Statistiques
Internationale
| Royaume-Uni | 2 |
Opérationnelle
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
 | Health Technology |
- Bourse
- Insiders
- Liz Elmhirst
- Expérience
